GL
DXCM icon

Graypoint LLC’s DexCom DXCM Stock Holding History

Graypoint LLC’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,047
Closed -$345K – 495
2024
Q2 		$345K Buy
3,047
+4
+0.1% +$506 0.02% 354
2024
Q1 		$422K Buy
3,043
+5
+0.2% +$628 0.03% 316
2023
Q4 		$377K Buy
+3,038
New +$310K 0.03% 309
2023
Q3 		– Sell
-2,493
Closed -$320K – 412
2023
Q2 		$320K Buy
2,493
+561
+29% +$67.9K 0.03% 294
2023
Q1 		$224K Buy
1,932
+110
+6% +$12.3K 0.02% 326
2022
Q4 		$206K Buy
+1,822
New +$200K 0.02% 318

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Graypoint LLC's DXCM Position: Q3 2024 in Review

Graypoint LLC sold out of DexCom (DXCM) in Q3 2024, closing a stake of 3,047 shares — an estimated $345K sold.

Graypoint LLC first reported a position in DXCM in Q4 2022 and held it in 6 quarters. The position peaked at $422K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Graypoint LLC reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Graypoint LLC sold 3,047 DexCom shares in Q3 2024, an estimated $345K.
  • Graypoint LLC first reported a position in DexCom in Q4 2022 and held it in 6 quarters.
  • Graypoint LLC's DexCom position peaked at $422K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Graypoint LLC's 13F filing for Q3 2024, filed 31 Oct 2024.